In addition, treatment of a mouse model of spinal muscular atrophy (SMA) with a soluble fragment of the synaptic organiser protein agrin, lead to improved motor performance and increased life span [44]. The gene discussed is PROS1; the disease is proximal spinal muscular atrophy.